Abstract:Transcriptome profiling of hepatocellular carcinoma (HCC) by next-generation sequencing (NGS) technology has been broadly performed by previous studies, which facilitate our understanding of the molecular mechanisms of HCC formation, progression, and metastasis. However, few studies jointly analyze multiple types of noncoding RNAs (ncRNAs), including long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and micro-RNAs (miRNAs), and further uncover their implications in HCC. In this study, we observed that the circRNA cZRANB1 and lncRNA DUXAP10 were not only significantly upregulated in tumor tissues, but also higher expressed in blood exosomes of HCC as compared with healthy donors. From the analysis of subclass-associated dysregulated ncRNAs, we observed that DLX6-AS1, an antisense RNA of DLX6, and the sense gene DLX6 were highly expressed in S1, a subclass with a more invasive/disseminative phenotype. High correlation between DLX6-AS1 and DLX6 suggested that DLX6-AS1 may function via promoting the transcription of DLX6. Integrative analysis uncovers circRNA-miRNA, lncRNA-miRNA, and competing endogenous RNA networks (ceRNAs). Specifically, cZRANB1, LINC00501, CTD-2008L17.2, and SLC7A11-AS1 may function as ceRNAs that regulate mRNAs by competing the shared miRNAs. Further prognostic analysis demonstrated that the dysregulated ncRNAs had the potential to predict HCC patients' overall survival. In summary, we identified some novel circRNAs and miRNAs, and dysregulated ncRNAs that could participate in HCC tumorigenesis and progression by inducing transcription of their neighboring genes, increasing their derived miRNAs, or acting as miRNA sponges. Moreover, our systematic analysis provides not only rich data resources for related researchers, but also new insights into the molecular basis of how different ncRNAs coordinately or antagonistically participate in the pathogenesis process of diseases.

Long non-coding RNAs in hepatocellular carcinoma: Ordering of the complicated lncRNA regulatory network and novel strategies for HCC clinical diagnosis and treatment

Transcriptome Sequencing of Hepatocellular Carcinoma Uncovers Multiple Types of Dysregulated Ncrnas

Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma

Functional long non-coding RNAs in hepatocellular carcinoma

The Paradoxical Functions of Long Noncoding RNAs in Hepatocellular Carcinoma: Implications in Therapeutic Opportunities and Precision Medicine

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma

The role of long noncoding RNAs in hepatocellular carcinoma.

Progress and Prospects of Long Noncoding RNAs (lncrnas) in Hepatocellular Carcinoma.

Long non-coding RNAs in hepatocellular carcinoma

The role of long non-coding RNA in hepatocellular carcinoma

Long Non-Coding RNAs As Biomarkers and Therapeutic Targets: Recent Insights into Hepatocellular Carcinoma.

Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma

Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials

Long Non-Coding RNAs: Critical Players in Hepatocellular Carcinoma

Expression Levels of Lncrnas Are Prognostic for Hepatocellular Carcinoma Overall Survival.

Long Noncoding Rnas In Hepatocellular Carcinoma: Novel Insights Into Their Mechanism

Regulatory mechanism of long non-coding RNA and advances of hepatocellular carcinoma

Research progresses of long noncoding RNA in hepatocellular carcinoma

Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis

Down-regulation of Long Non-coding RNA LINC01554 in Hepatocellular Cancer and Its Clinical Significance.

The roles of lncRNA functions and regulatory mechanisms in the diagnosis and treatment of hepatocellular carcinoma